EPHA2 and neoplasm: After studying single-cell coexpression patterns of the TAAs HER2, IL-13Rα2, and EphA2 in primary GBM samples, Hegde et al. developed a mathematical model of antigen expression to predict the odds of complete tumor elimination with CART therapy.